NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Circe Bioscience

Circe Bioscience

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://circe.bio/

Last Round

Seed

Sep 12, 2024

Total Funding Raised

$13.37M

Company Overview

Circe Bioscience is a biotechnology company that develops gas fermentation technology to convert carbon dioxide into sustainable, nature-identical fats, oils, and other organic compounds.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Carbon Capture, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

gas fermentationsynthetic biologybiomanufacturingsustainable fatscarbon capturebio-based ingredientsengineered microbesalternative proteinsfood techclimate techprecision fermentationsustainable oilscarbon-negativebiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Circe Bioscience Comparables

Compare Circe Bioscience with similar companies based on industry and business-model similarity.

Circe Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
COLIPI
84%
Green-On
84%
Seminal Biosciences
82%

Circe Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 12, 2024
GrantJul 11, 2024
GrantMay 1, 2021

Key People

Founding team and executive leadership

Shannon Nangle

Co-founder CEO

Founding Team

Circe Bioscience Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 12, 2024

    $5M round with participation from Bee Partners and Climate Capital.

  • Jul 11, 2024

    $1.5M grant awarded by MassTech Collaborative

Circe Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Circe Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Circe Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersWaltham, Massachusetts
Employee Range2
Year Founded2021
Last FundingSep 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.